Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Applied Digitals quarterly results drew attention after a sharp revenue and adjusted-earnings beat, but the stocks muted reaction prompted debate over the large GAAP loss, lumpy tenant fit-out revenue, and heavy debt and spending. Bulls focused on growth and data-center expansion, while skeptics looked for clearer guidance on recurring revenue and financing.

A House Select Committee on China report alleging structural ties between Webull and China has driven a sharp selloff, with traders debating potential data, customer-cash and regulatory risks. Webull disputes the reports conclusions, and the community is split between selling or moving assets to other brokers and treating the drop as an overreaction and buying opportunity.

Wolfspeeds conditional federal loan commitment to expand U.S. silicon-carbide and GaN production is driving attention, with traders framing it as financing support and a possible short-squeeze catalyst. Others caution that the commitment is conditional and that the companys losses and cash burn remain concerns.

BlackBerry is drawing attention for a sharp pullback that traders say erased recent gains despite no clear company-specific news; some attribute the move to technical selling or broader market pressure, while others allege manipulation. Longs describe the decline as a buying opportunity and point to QNXs growth prospects, while skeptics question the companys revenue growth and management.

Rivians funding of a Volkswagen-backed $1 billion, 10-year non-recourse loan is drawing attention, with traders viewing the financingsecured by its joint-venture stakeas supportive while noting the shares showed little immediate reaction. Some bullish posts see it as reducing near-term funding pressure, though that optimism is not shared by all traders.

Capricors PPMD presentation of additional deramiocel data and robustness analyses for Duchenne muscular dystrophy has renewed attention ahead of the FDA decision. Many traders view the findings as strengthening the case for approval, while others emphasize unresolved statistical concerns and the possibility of a rejection or further delay.

PepsiCo is under pressure near 52-week lows as traders focus on upcoming Q3 results and analyst downgrades citing weak North American trends, especially Frito-Lay, amid strained consumer demand. Bears see room for further declines, while value-focused investors point to oversold conditions and the dividend as reasons to accumulate.

An attempted rebound through the $45 resistance has fueled bullish calls for a breakout and short squeeze, alongside widespread but unsubstantiated speculation that SpaceX could buy Super Micro or place major AI-server orders. Some traders view the SpaceX chatter as a catalyst, while others dismiss it as rumor and point to the stocks volatile, difficult-to-sustain gains.

NEARs rally is being linked by traders to the launch of confidential perpetuals powered by Hyperliquid, alongside interest in its AI-agent and cross-chain infrastructure narrative and Bitwise ETF developments. Bullish momentum and dip-buying are tempered by concerns over a reported NEAR Intents exploit and whether it could undermine trust.

UnitedHealth is drawing attention ahead of its Q3 earnings report, with traders also watching Medicare Advantage star ratings and regulatory scrutiny as potential risks. The stocks prolonged decline has fueled debate between bulls expecting an earnings-driven rebound and bears positioning for further losses.